Evidence map›Paper›PMID 42252459›Full record

ArticleEcho research and practice2026

The impact of right ventricular free wall strain on current international echocardiography guidelines for the assessment of pulmonary hypertension.

C J B Wild, G Coghlan, A Charalampopoulos, A Hameed, J Suntharalingam, R Mackenzie Ross, D Knight, J Willis, J Page, A Gurung and 6 more

Abstract read
In one paragraph

Article in Echo research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

C J B WildRoyal United Hospitals Bath NHS Foundation Trust, Bath, UK.
G CoghlanRoyal Free Hospital NHS Foundation Trust, London, UK.
A CharalampopoulosSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
A HameedSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
J SuntharalingamRoyal United Hospitals Bath NHS Foundation Trust, Bath, UK.
R Mackenzie RossRoyal United Hospitals Bath NHS Foundation Trust, Bath, UK.
D KnightRoyal Free Hospital NHS Foundation Trust, London, UK.
J WillisRoyal United Hospitals Bath NHS Foundation Trust, Bath, UK.
J PageRoyal United Hospitals Bath NHS Foundation Trust, Bath, UK.
A GurungRoyal United Hospitals Bath NHS Foundation Trust, Bath, UK.
M JohnsonGolden Jubilee Hospital, Glasgow, UK.
N KariaRoyal Free Hospital NHS Foundation Trust, London, UK.
D OxboroughLiverpool John Moores University, Liverpool, UK.
O PeacockDepartment for Health, University of Bath, Bath, UK.
D ThompsonDepartment for Health, University of Bath, Bath, UK.
D X AugustineRoyal United Hospitals Bath NHS Foundation Trust, Bath, UK. daniel.augustine@nhs.net.ORCID https://orcid.org/0000-0002-7617-9380

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrent guidelines define pulmonary hypertension (PH) as a mean pulmonary artery pressure (mPAP) >20mmHg at right heart catheterisation (RHC). International transthoracic echocardiography (TTE) PH guidelines recommend a multi-parameter assessment to estimate PH probability. Effectiveness of the inclusion of right ventricular free wall strain (RVFWS) has not been established using real world data. STUDY

aimsTo determine the accuracy of current European and American TTE PH guidance in detecting PH in patients attending a UK PH centre. The impact of addition of RVFWS to the efficacy of the European and American guidance was also evaluated.

methodsTTE with subsequent RHC (within 1.4 months) were undertaken in patients with suspicion of PH, referred for first time investigations. Echocardiographic variables were assessed in accordance with current European and American TTE guidance.

resultsOf 549 patients assessed, 431 (79%) had RHC confirmed PH (average mPAP = 41mmHg). Sensitivity / specificity for detecting PH was calculated for the European Society of Cardiology (ESC) TTE PH recommendations (83% / 65% respectively); ESC + RVFWS (92% / 62% respectively); American Society of Echocardiography (ASE) TTE PH recommendations (89% / 49% respectively); ASE + RVFWS (96% / 36% respectively); TTE PASP > 35mmHg alone (75% / 73% respectively); TTE TRV > 2.8 m/s alone (77% / 78% respectively). Of those with RHC PH 3 (1%) subjects with a TRV > 2.8 m/s and 7 (3%) with a PASP > 35mmHg had no supporting signs of PH. Using TTE PASP > 35mmHg or TRV >2.8m/s with at least 2 abnormal TTE parameters (including RVFWS) gave similar sensitivity / specificity (74% / 79% vs 73% / 87% respectively). In those with RHC PH and TTE PASP >35mmHg or TRV >2.8m/s the significant majority had at least 2 TTE PH markers (99% & 97%). Whilst TTE PASP and RHC PASP correlation was good (r = 0.745), accuracy was poor with limits of agreements as high as 44mmHg (range = -29 to 44mmHg). In those with no measurable tricuspid regurgitation, 64% (n = 49) had RHC PH (11% of whole cohort); in those where TTE PASP <35mmHg 23% (n = 70) had RHC PH. In those felt to have an ESC PH low TTE probability 44% (n = 60) had RHC PH (14% of whole cohort). Incorporating RVFWS improved detection in those with a ESC low TTE PH probability, reducing false negatives by 43%.

conclusionCurrent TTE PH algorithms lack sensitivity to detect patients with milder haemodynamic forms of PH. This can be improved with the addition of RVFWS.

Indexed as

EchocardiographyPulmonary hypertensionRight ventricular free wall longitudinal strain

Identifiers

PMID42252459
PMCPMC13244624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.